全文获取类型
收费全文 | 19460篇 |
免费 | 1525篇 |
国内免费 | 572篇 |
专业分类
耳鼻咽喉 | 172篇 |
儿科学 | 306篇 |
妇产科学 | 555篇 |
基础医学 | 2522篇 |
口腔科学 | 405篇 |
临床医学 | 2141篇 |
内科学 | 4067篇 |
皮肤病学 | 234篇 |
神经病学 | 1190篇 |
特种医学 | 467篇 |
外国民族医学 | 3篇 |
外科学 | 2638篇 |
综合类 | 1483篇 |
现状与发展 | 3篇 |
一般理论 | 5篇 |
预防医学 | 1074篇 |
眼科学 | 745篇 |
药学 | 1585篇 |
6篇 | |
中国医学 | 570篇 |
肿瘤学 | 1386篇 |
出版年
2024年 | 35篇 |
2023年 | 227篇 |
2022年 | 460篇 |
2021年 | 689篇 |
2020年 | 453篇 |
2019年 | 490篇 |
2018年 | 568篇 |
2017年 | 504篇 |
2016年 | 492篇 |
2015年 | 664篇 |
2014年 | 803篇 |
2013年 | 924篇 |
2012年 | 1387篇 |
2011年 | 1490篇 |
2010年 | 883篇 |
2009年 | 717篇 |
2008年 | 1088篇 |
2007年 | 1094篇 |
2006年 | 1140篇 |
2005年 | 1114篇 |
2004年 | 918篇 |
2003年 | 785篇 |
2002年 | 771篇 |
2001年 | 538篇 |
2000年 | 530篇 |
1999年 | 481篇 |
1998年 | 187篇 |
1997年 | 192篇 |
1996年 | 159篇 |
1995年 | 113篇 |
1994年 | 110篇 |
1993年 | 76篇 |
1992年 | 206篇 |
1991年 | 188篇 |
1990年 | 165篇 |
1989年 | 146篇 |
1988年 | 117篇 |
1987年 | 112篇 |
1986年 | 91篇 |
1985年 | 62篇 |
1984年 | 43篇 |
1983年 | 31篇 |
1982年 | 45篇 |
1981年 | 39篇 |
1980年 | 35篇 |
1979年 | 36篇 |
1978年 | 32篇 |
1977年 | 19篇 |
1975年 | 20篇 |
1973年 | 14篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
Identifying potential indicators of the quality of end-of-life cancer care from administrative data.
Craig C Earle Elyse R Park Bonnie Lai Jane C Weeks John Z Ayanian Susan Block 《Journal of clinical oncology》2003,21(6):1133-1138
PURPOSE: To explore potential indicators of the quality of end-of-life services for cancer patients that could be monitored using existing administrative data. METHODS: Quality indicators were identified and assessed by literature review for proposed indicators, focus groups with cancer patients and family members to assess candidate indicators and generate new ideas, and an expert panel ranking the meaningfulness and importance of each potential indicator using a modified Delphi approach. RESULTS: There were three major concepts of poor quality of end-of-life cancer care that could be examined using currently-available administrative data (such as Medicare claims): institution of new anticancer therapies or continuation of ongoing treatments very near death; a high number of emergency room visits, inpatient hospital admissions, or intensive care unit days near the end of life; and a high proportion of patients never enrolled in hospice, only admitted in the last few days of life, or dying in an acute-care setting. Concepts such as access to psychosocial and other multidisciplinary services and pain and symptom control are important and may eventually be feasible, but they cannot currently be applied in most data systems. Indicators based on limiting the use of treatments with low probability of benefit or indicators based on economic efficiency were not acceptable to patients, family members, or physicians. CONCLUSION: Several promising claims-based quality indicators were identified that, if found to be valid and reliable within data systems, could be useful in identifying health-care systems in need of improving end-of-life services. 相似文献
62.
Jong-Kai Hsiao Ming-Fong Tai Hung-Hao Chu Shin-Tai Chen Hung Li Dar-Ming Lai Sung-Tsang Hsieh Jaw-Lin Wang Hon-Man Liu 《Magnetic resonance in medicine》2007,58(4):717-724
The purpose of this work was to evaluate the efficacy of labeling human mesenchymal stem cells (hMSCs) by ionic superparamagnetic iron oxide (SPIO) without a transfection agent and verifying its capability to be detected with clinical 1.5 T magnetic resonance (MR) at the single-cell level. Human hMSCs were incubated for 24 h with an ionic SPIO, Ferucarbotran. The labeling efficiency of hMSCs was determined by iron content measurement spectrophotometrically, and the influence of labeling on cell behavior was ascertained by examination of cell viability using the trypan blue exclusion method, cell proliferation analysis using MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay, mitochondrial membrane potential (MMP) change, differentiation capacity, and reactive oxygen species (ROS) production measured by dichlorofluorescein diacetate (DCFDA) fluorescent probe. Labeled hMSCs were scanned under 1.5 T MRI with three-dimensional (3D) and two-dimensional (2D) T(2)-weighted gradient echo (GRE) pulse sequences. Human hMSC labeling without transfection agent was efficient. The iron content in hMSCs was 23.4 pg Fe/cell. No significant change was found in viability, proliferation, MMP change, ROS production, or differentiation capacity. About 45.2% of the hMSCs could be detected using 1.5 T MRI at the single cell level with 3D GRE and four repetitions. 相似文献
63.
Post-injury regeneration in rat sciatic nerve facilitated by neurotrophic factors secreted by amniotic fluid mesenchymal stem cells. 总被引:1,自引:0,他引:1
Hung-Chuan Pan Fu-Chou Cheng Chun-Jung Chen Shu-Zhen Lai Chi-Wen Lee Dar-Yu Yang Ming-Hong Chang Shu-Peng Ho 《Journal of clinical neuroscience》2007,14(11):1089-1098
Amniotic fluid mesenchymal stem cells have the ability to secrete neurotrophic factors that are able to promote neuron survival in vitro. The purpose of this study was to evaluate the effects of neurotrophic factors secreted by rat amniotic fluid mesenchymal stem cells on regeneration of sciatic nerve after crush injury. Fifty Sprague-Dawley rats weighing 250-300 g were used. The left sciatic nerve was crushed with a vessel clamp. Rat amniotic fluid mesenchymal stem cells embedded in fibrin glue were delivered to the injured nerve. Enzyme-linked immunosorbent assay (ELISA) and immunocytochemistry were used to detect neurotrophic factors secreted by the amniotic fluid mesenchymal stem cells. Nerve regeneration was assessed by motor function, electrophysiology, histology, and immunocytochemistry studies. Positive CD29/44, and negative CD11b/45, as well as high levels of expression of brain-derived neurotrophic factor, glia cell line-derived neurotrophic factor, ciliary neurotrophic factor (CNTF), nerve growth factor, and neurotrophin-3 (NT-3) were demonstrated in amniotic fluid mesenchymal stem cells. Motor function recovery, the compound muscle action potential, and nerve conduction latency showed significant improvement in rats treated with amniotic fluid mesenchymal stem cells. ELISA measurement in retrieved nerves displayed statistically significant elevation of CNTF and NT-3. The immunocytochemical studies demonstrated positive staining for NT-3 and CNTF in transplanted cells. The histology and immunocytochemistry studies revealed less fibrosis and a high level of expression of S-100 and glial fibrillary acid protein at the crush site. Rat amniotic fluid mesenchymal stem cells may facilitate regeneration in the sciatic nerve after crush injury. The increased nerve regeneration found in this study may be due to the neurotrophic factors secreted by amniotic fluid mesenchymal stem cells. 相似文献
64.
Ming-Shian Tsai Wen-Hsi Lin Wen-Ming Hsu Hong-Shiee Lai Po-Huang Lee Wei-Jao Chen 《Journal of gastrointestinal surgery》2008,12(12):2191-2195
Background/aims Surgical resection of choledochal cysts (CC) has become standard treatment. However, surgery is not universally recommended
in early infancy and/or asymptomatic patients. In order to investigate the optimal timing of CC excision, we analyzed clinicopathological
data and surgical results from different age groups.
Material and methods This retrospective review included 107 patients (77 females, 30 males) who underwent CC resection at the National Taiwan University
Hospital between January 1988 and December 2005. Patient demographic, clinical, and surgical data were collected and analyzed.
Results The patients were divided into three groups according to age at the time of surgery: <1 year old (group I, n = 26), 1−16 years old (group II, n = 48), and >16 years old (group III, n = 33). About two thirds of the patients in group I had jaundice, while abdominal pain related to inflammation was the commonest
symptom in groups II and III. Group I suffered significantly fewer surgical complications and less severe liver fibrosis than
groups II or III.
Conclusion CC surgery in infancy and in asymptomatic patients is safe and may prevent the complications of this condition. The results
support a recommendation for early excision. 相似文献
65.
66.
目的探讨第一、二鳃弓综合征面部不对称畸形的整形外科矫治方法。方法根据第一、二鳃弓综合征患者临床及X线所示面部双侧不对称情况,采用健侧下颌骨外板去除、颧骨截骨降低;患侧下颌体、颧骨应用健侧下颌骨外板贴附植骨或高密度多孔聚乙烯(Medpor)假体置入等术式,配合颏部水平截骨颏成形术,以缩小面部双侧宽度的差异,矫治颜面不对称畸形。结果共矫治23例,经6个月至3年的术后随访观察,双侧面部宽度差异明显缩小,正面观面部不对称明显改善。结论第一、二鳃弓综合征面部骨骼发育畸形是三维方向的,双侧面骨宽度的差异,是造成正面观面部不对称的重要因素,根据受术者的具体情况,采用以上术式的组合,扩充患侧或同时缩窄健侧骨骼,进行面部骨性支架重建,可以取得良好的矫治效果。 相似文献
67.
Vanessa Vu J. Carl Barrett Joseph Roycroft Loretta Schuman David Dankovic Paul BBaro Ted Martonen William Pepelko David Lai 《Regulatory toxicology and pharmacology : RTP》1996,24(3):202-212
On May 8–10, 1995, a workshop on chronic inhalation toxicity and carcinogenicity testing of respirable fibrous particles was held in Chapel Hill, North Carolina. The workshop was sponsored by the Office of Pollution Prevention and Toxics, U.S. Environmental Protection Agency (EPA), in collaboration with the National Institute of Environmental Health Sciences (NIEHS), the National Institute for Occupational Safety and Health (NIOSH), and the Occupational Safety and Health Administration (OSHA). The goal of the workshop was to obtain input from the scientific community on a number of issues related to fiber testing. Major issues for discussion were: (i) the optimal design and conduct of studies of the health effects of chronic inhalation exposure of animals to fibers; (ii) preliminary studies which would be useful guides in designing the chronic exposure study; (iii) mechanistic studies which would be important adjuncts to the chronic exposure study to enable better interpretation of study results and extrapolation of potential effects in exposed humans; and (iv) available screening tests which can be used to develop a minimum data set for (a) making decisions about the potential health hazard of the fibers and (b) prioritizing the need for further testing in a chronic inhalation study. After extensive discussion and debate of the workshop issues, the general consensus of the expert panel is that chronic inhalation studies of fibers in the rat are the most appropriate tests for predicting inhalation hazard and risk of fibers to humans. A number of guidances specific for the design and conduct of prechronic and chronic inhalation studies of fibers in rodents were recommended. For instance, it was recommended that along with other information (decrease in body weight, systemic toxicity, etc.), data should be obtained on lung burdens and bronchoalveolar lavage fluid analysis to assist in establishing the chronic exposure levels. Lung burden data are also important for quantifying aspects of risk assessment related to dosimetric adjustments before extrapolation. Although mechanistic studies are not recommended as part of the standard chronic inhalation studies, the expert panel stressed the need for obtaining mechanistic information as far as possible during the course of subchronic or chronic inhalation studies. At present, no single assay and battery of short-term assays can predict the outcome of a chronic inhalation bioassay with respect to carcinogenic effects. Meanwhile, several short-termin vitroandin vivostudies that may be useful to assess the relative potential of fibrous substances to cause lung toxicity/carcinogenicity have been identified. 相似文献
68.
光照疗法对新生儿红细胞谷胱甘肽还原酶活性的影响 总被引:3,自引:0,他引:3
作者对光照疗法(光疗)前及光疗后于口服维生素B_2(43例)和不予口服维生素B_2(17例)的黄疸新生儿的红细胞谷胱甘肽还原酶(GR)的活性进行了动态观察。结果显示,接受短期光疗的黄疸新生儿其红细胞GR活性较光疗前的GR活性有显著下降,光疗后予口服维生素B_2可使下降的红细胞GR活性回升,而不予补充维生素B_2者的红细胞GR活性继续下降。光疗的时间越长,红细胞GR活性的下降越明显,补充维生素B_2使红细胞GR活性回复到正常水平所需的时间也越长。短期光疗也可引起体内维生素B_2的降解,导致红细胞GR活性的下降,为避免因红细胞GR活性下降引起的红细胞额外破坏,对接受光疗的黄疸新生儿常规补充维生素B_2的是必要的。 相似文献
69.
Naoki Sugawara Koji Arizono Toshiichi Kitajima Hideaki Inoue Yu-Rong Lai 《Archives of toxicology》1997,71(5):336-339
A new mutant, the Eisai hyperbilirubinemic (EHB) rat, shows no inherent expression of the canalicular isoform of the multidrug
resistance protein (cMrp) in the liver. It has defective biliary secretion of organic anions such as bilirubin glucuronides,
bromosulfophthalein (BSP), cysteinyl leukotrienes, glutathione (GSH) and bile acid sulfate and glucuronides. When rats were
injected intravenously with CdCl2, biliary excretion of Cd over 30 min was 0.28% and 0.004% of the total dose in Sprague-Dawley (SD) and EHB rats, respectively.
Six SD rats and five EHB rats were fed a diet containing Cd. Bile Cd was detected at the level of 2 ng/20 min in SD rats,
but not in EHB rats. There was no significant difference of hepatic Cd concentration between SD and EHB rats. Furthermore,
there were no significant differences of renal and intestinal Cd, and hepatic and renal metallothionein (MT) concentrations
between the SD and EHB groups. Biliary excretion of reduced-GSH for 20 min was 1.3 ± 0.3 mg and 3.6 ± 0.9 μg in SD and EHB
rats, respectively. Our results suggest that hepatobiliary excretion of exogenous Cd is mediated mainly via carrier transport,
including a cMrp or GSH carrier, but that the lack of the transport pathway does not contribute to abnormal accumulation of
Cd in the liver.
Received: 12 August 1996 / Accepted 7 November 1996 相似文献
70.
The use of item banks and computerized adaptive testing (CAT) begins with clear definitions of important outcomes, and references those definitions to specific questions gathered into large and well-studied pools, or “banks” of items. Items can be selected from the bank to form customized short scales, or can be administered in a sequence and length determined by a computer programmed for precision and clinical relevance. Although far from perfect, such item banks can form a common definition and understanding of human symptoms and functional problems such as fatigue, pain, depression, mobility, social function, sensory function, and many other health concepts that we can only measure by asking people directly. The support of the National Institutes of Health (NIH), as witnessed by its cooperative agreement with measurement experts through the NIH Roadmap Initiative known as PROMIS (www.nihpromis.org), is a big step in that direction. Our approach to item banking and CAT is practical; as focused on application as it is on science or theory. From a practical perspective, we frequently must decide whether to re-write and retest an item, add more items to fill gaps (often at the ceiling of the measure), re-test a bank after some modifications, or split up a bank into units that are more unidimensional, yet less clinically relevant or complete. These decisions are not easy, and yet they are rarely unforgiving. We encourage people to build practical tools that are capable of producing multiple short form measures and CAT administrations from common banks, and to further our understanding of these banks with various clinical populations and ages, so that with time the scores that emerge from these many activities begin to have not only a common metric and range, but a shared meaning and understanding across users. In this paper, we provide an overview of item banking and CAT, discuss our approach to item banking and its byproducts, describe testing options, discuss an example of CAT for fatigue, and discuss models for long term sustainability of an entity such as PROMIS. Some barriers to success include limitations in the methods themselves, controversies and disagreements across approaches, and end-user reluctance to move away from the familiar. 相似文献